^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Soft Tissue Sarcoma
    Regimen: (doxorubicin hydrochloride + ifosfamide + methotrexate IV)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Soft Tissue Sarcoma: Preferred Regimens…AIM (doxorubicin, ifosfamide, mesna)